Linkage to office-based buprenorphine treatment reduced illicit opioid use and increased days of buprenorphine treatment in patients discharged from a short-term detoxification program.
Federal health officials have proposed a revamp of patient confidentiality regulations to encourage coordination among medical professionals treating people for opioid addiction.
A fivefold increase was seen in Medicaid-covered prescriptions for buprenorphine during 2011 to 2018.
Adults who take prescription opioids for severe chronic pain are more likely to have increased anxiety, depression, and substance abuse issues if they also use cannabis.
Regional variation in naloxone dispensing considerable; rates lowest in most rural counties.
The convenience and confidentiality of computer-based and mobile technologies may encourage more individuals with substance use disorders to access treatment.
Rates of treatment are low for parents with opioid use disorder (OUD) or other substance use disorders.
From 2017 to 2018, there was a decrease in heroin overdose emergency department visits, although the declines were not consistent among states.
Monthly injections of naltrexone extended-release may induce a dysphoric state and suicidal ideation in some patients.
Machine-learning algorithms that incorporate administrative data and deep learning may be effective for predicting risk for opioid overdose and for identifying patients at low risk for overdose.
